Godavari Drugs Limited (BOM:530317)

Godavari Drugs Statistics

Total Valuation

Godavari Drugs has a market cap or net worth of INR 657.11 million. The enterprise value is 1.37 billion.

Market Cap	657.11M
Enterprise Value	1.37B

Important Dates

The next estimated earnings date is Saturday, February 14, 2026.

Earnings Date	Feb 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Godavari Drugs has 7.53 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	7.53M
Shares Outstanding	7.53M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	-0.22%
Owned by Insiders (%)	58.37%
Owned by Institutions (%)	n/a
Float	2.84M

Valuation Ratios

The trailing PE ratio is 17.77.

PE Ratio	17.77
Forward PE	n/a
PS Ratio	0.67
PB Ratio	1.45
P/TBV Ratio	1.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	37.21
EV / Sales	1.39
EV / EBITDA	12.16
EV / EBIT	15.52
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	1.63
Debt / EBITDA	6.54
Debt / FCF	n/a
Interest Coverage	2.14

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.34%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	4.69%
Revenue Per Employee	9.31M
Profits Per Employee	348,255
Employee Count	106
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Godavari Drugs has paid 11.94 million in taxes.

Income Tax	11.94M
Effective Tax Rate	24.44%

Stock Price Statistics

The stock price has decreased by -8.93% in the last 52 weeks. The beta is 0.17, so Godavari Drugs's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	-8.93%
50-Day Moving Average	83.79
200-Day Moving Average	86.48
Relative Strength Index (RSI)	48.66
Average Volume (20 Days)	6,120

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Godavari Drugs had revenue of INR 986.94 million and earned 36.92 million in profits. Earnings per share was 4.91.

Revenue	986.94M
Gross Profit	277.63M
Operating Income	88.50M
Pretax Income	48.85M
Net Income	36.92M
EBITDA	112.98M
EBIT	88.50M
Earnings Per Share (EPS)	4.91

Balance Sheet

The company has 22.93 million in cash and 739.28 million in debt, with a net cash position of -716.35 million or -95.13 per share.

Cash & Cash Equivalents	22.93M
Total Debt	739.28M
Net Cash	-716.35M
Net Cash Per Share	-95.13
Equity (Book Value)	453.87M
Book Value Per Share	60.32
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 28.13%, with operating and profit margins of 8.97% and 3.74%.

Gross Margin	28.13%
Operating Margin	8.97%
Pretax Margin	4.95%
Profit Margin	3.74%
EBITDA Margin	11.45%
EBIT Margin	8.97%
FCF Margin	n/a

Dividends & Yields

Godavari Drugs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	0.00%
Earnings Yield	5.62%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2